Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for Endothelial Damage in Knee Surgery
NCT03772054Completed
- Sponsor
- Universidad de Chile
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of sevoflurane in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Universidad de Chile. Primary endpoint: Syndecan-1 levels. Started Dec 2018; status: completed.
02
Drugs
sevoflurane
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT03772054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772054.